請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/4691
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 謝松蒼(Sung-Tsang Hsieh) | |
dc.contributor.author | Ching-Yu Chen | en |
dc.contributor.author | 陳璟瑜 | zh_TW |
dc.date.accessioned | 2021-05-14T17:45:21Z | - |
dc.date.available | 2020-09-25 | |
dc.date.available | 2021-05-14T17:45:21Z | - |
dc.date.copyright | 2015-09-25 | |
dc.date.issued | 2015 | |
dc.date.submitted | 2015-07-14 | |
dc.identifier.citation | [1] Abbracchio, M.P. and Burnstock, G., “Purinoceptors: Are there families of P2X and P2Y purinoceptors,” Pharmacology & Therapeutics, vol. 64, pp. 445-475, 1994.
[2] Alec B. O’Connor, Robert H. Dworkin, “Treatment of Neuropathic Pain: An Overview of Recent Guidelines,” The American Journal of Medicine, vol. 122, pp. S22–S32, 2009. [3] Alexandra Hovaguimian, Christopher H. Gibbons, “Diagnosis and Treatment of Pain in Small Fiber Neuropathy,” Current Pain and Headache Reports, vol. 15(3), pp. 193–200, 2011. [4] Alessia Franceschini, Elena Adinolfi, “P2X receptors: New players in cancer pain,” World Journal of Biological Chemistry, vol. 5(4), pp. 429-436, 2014. [5] Anthony P. Ford, Bradley J. Undem, “The therapeutic promise of ATP antagonism at P2X3 receptors in respiratory and urological disorders,” Frontiers in Cellular Neuroscience, vol. 7, article 267, pp. 1-10, 2013. [6] Anne-Fre’de’rique Bourquin, Maria Suveges, Marie Pertin, Nicolas Gilliard, Sylvain Sardy, Anthony C. Davison, Donat R. Spahn, Isabelle Decosterd, “Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse,” Pain, vol. 122, 14.e1–14.e14, 2006. [7] Amanda K Smith, Crystal L O’Hara and Cheryl L Stucky, “Mechanical sensitization of cutaneous sensory fibers in the spared nerve injury mouse model,” Molecular Pain, vol. 9, pp. 61-66, 2013. [8] Baljit S. Khakh, “Molecular physiology of P2X receptors and ATP signaling at synapses,” Nature Reviews, vol. 2, pp. 165-174. 2001. [9] Cédric J Laedermann, Marie Pertin, Marc R Suter, Isabelle Decosterd, “Voltage-gated sodium channel expression in mouse DRG after SNI leads to re-evaluation of projections of injured fibers,” Molecular Pain, vol. 10:19, 2014. [10] Chlh- Chen Chen, Armen N. Akopian, Lucla Sivilotti, David Colquhoun, Geoffrey Burnstock, John N. Wood, “A P2X purinoceptor expressed by a subset of sensory neurons,” Nature, vol. 377, pp. 428-431, 1995. [11] Dimitra Terzi, Sevasti Gaspari, Lefteris Manouras, Giannina Descalzi, Vassiliki Mitsi, Venetia Zachariou, “RGS9-2 modulates sensory and mood related symptoms of neuropathic pain,” Neurobiology of Learning and Memory, vol. 115, pp. 43-46, 2014. [12] E. Pryazhnikov, D. Fayuk, M. Niittykoski, Rashid Giniatullin, Leonard Khiroug, “Unusually strong temperature dependence of P2X3 receptor traffic to the plasma membrane,” Frontiers in Cellular Neuroscience, vol. 5, article 27, pp. 1-9, 2011. [13] Emerson Marcelo Motta, Joao Batista Calixto, Giles Alexander Rae, “Mechanical Hyperalgesia Induced by Endothelin-1 in Rats Is Mediated Via Phospholipase C, Protein Kinase C, and MAP Kinases,” Experimental Biology and Medicine, vol. 231(6), pp. 1141-5, 2006. [14] Geoffrey Burnstock, “Purinergic mechanismsandpain—an update,” European Journal of Pharmacology, vol. 716, pp. 24–40, 2013. [15] Geoffrey Burnstock, “Purinergic Receptors and Pain,” Current Pharmaceutical Design, vol. 15, no. 00, 2009. [16] Giorgia D. Ugarte, Tatiana Opazo, Francisco Leisewitz, Brigitte Van Zundert, Martin Montecino, “Runx1 and C/EBPb transcription factors directly up-regulate P2X3 gene transcription,” Journal of Cellular Physiology, pp. 1645-1652, 2011. [17] Hao-Jui Weng, Kush N. Patel, Nathaniel A. Jeske, Sonya M. Bierbower, Wangyuan Zou, Vinod Tiwari, Qin Zheng, Zongxiang Tang, Gary C.H. Mo, Yan Wang, Yixun Geng, Jin Zhang, Yun Guan, Armen N. Akopian, Xinzhong Dong, “Tmem100 Is a regulator of TRPA1-TRPV1 complex and contributes to persistent pain,” Neuron, vol. 85(4), pp. 833-46, 2015. [18] H. Schmalbruch, “Fiber composition of the rat sciatic nerve,” The Anatomical Record, vol. 215, pp. 71-81, 1986. [19] Hans Lindå, MattiasK.Sköld, ThomasOchsmann, “Activating transcription factor 3, a useful marker for regenerative response after nerve root injury,” Frontiers in Neurology, vol. 2, article 30, pp. 1-6, 2011. [20] Hiroaki Tsujino, Eiji Kondo, Tetsuo Fukuoka, Yi Dai, Atsushi Tokunaga, Kenji Miki, Kazuo Yonenobu, Takahiro Ochi, Koichi Noguchi, “Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: A novel neuronal marker of nerve Injury,” Molecular and Cellular Neuroscience, vol. 15, pp. 170–182, 2000. [21] Ian Gilron, Troels S Jensen, Anthony H Dickenson, “Combination pharmacotherapy for management of chronic pain: from bench to bedside,” The Lancet Neurology, vol. 12, pp. 1084-95, 2013. [22] Isabelle Decosterd, Clifford J. Woolf, “Spared nerve injury: an animal model of persistent peripheral neuropathic pain,” Pain, vol. 87, pp.149-158, 2000. [23] Jean-Marie Peyronnard, Louise Charron, “Motor and sensory neurons of the rat sural nerve: a horseradish peroxidase study,” Muscle & Nerve, vol. 5, pp. 654-660, 1982. [24] John Scadding, “Neuropathic pain,” Advances in clinical neuroscience & rehabilitation, vol. 3, 2003. [25] John E. Swett, Yasuhiro Torigoe, Vincent R. Elie, Charles M. Bourassa, Peter G. Miller, “Sensory neurons of the rat sciatic nerve,” Experimental Neurology, vol. 114, pp. 82-103, 1991. [26] J. Eriksson, U. Bongenhielm, E. Kidd, B. Matthews, K. Fried, “Distribution of P2X3 receptors in the rat trigeminal ganglion after inferior alveolar nerve injury,” Neuroscience Letters, vol. 254, pp. 37–40, 1998. [27] Karen Kage, Wende Niforatos, Chang Z. Zhu, Kevin J. Lynch, Prisca Honore, Michael F. Jarvis, “Alteration of dorsal root ganglion P2X3 receptor expression and function following spinal nerve ligation in the rat,” Experimental Brain Research, vol. 147, pp. 511-519, 2002. [28] Kata Boぴlcskei1, Zsuzsanna Helyes, A´ rpa´d Szabo´, Katalin Sa´ndor, Krisztia´n Elekes, Jo´zsef Ne´meth, Ro´bert Alma´si, Erika Pinte´r, Ga´bor Petho˝, Ja´nos Szolcsa´nyi, “Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice,” Pain, vol. 117, pp. 368–376, 2005. [29] Kenjiro Nagamine, Noriyuki Ozaki, Masamichi Shinoda, Hideaki Asai, Hiroaki Nishiguchi, Kenji Mitsudo, Iwai Tohnai, Minoru Ueda, Yasuo Sugiura, “Mechanical Allodynia and Thermal Hyperalgesia Induced by Experimental Squamous Cell Carcinoma of the Lower Gingiva in Rats,” The Journal of Pain, vol. 7, No. 9, pp. 659-670, 2006. [30] Kerstin Wirkner, Beata Sperlagh, Peter Illes, “P2X3 Receptor Involvement in Pain States,” Molecular Neurobiology, vol. 36, pp. 165–183, 2007. [31] Kenzo Tsuzuki, Eiji Kondo, Tetsuo Fukuoka, Dai Yi, Hiroaki Tsujino, Masafumi Sakagami, Koichi Noguchi, “Differential regulation of P2X3 mRNA expression by peripheral nerve injury in intact and injured neurons in the rat sensory ganglia,” Pain, vol. 91, pp. 351-360, 2001. [32] Khakh, B.S., “Molecular physiology of P2X receptors and ATP signalling at synapses,” Nature Reviews, vol. 2, pp. 165-174, 2001. [33] Liron S Duraku, Mehdi Hossaini, Sieske Hoendervangers, Lukas L Falke, Shoista Kambiz, Vivek C Mudera, Joan C Holstege, Erik T Walbeehm, Tom J H Ruigrok, “Spatiotemporal dynamics of re-innervation and hyperinnervation patterns by uninjured CGRP fibers in the rat foot sole epidermis after nerve injury,” Molecular Pain, vol. 8, pp. 61-73, 2012. [34] L. Vulchanova, M. S. Riedl, S. J. Stone, K. M. Hargreaves, G. Buell, A. Surprenant, R. A. North, R. Elde, “P2X3 is expressed by DRG neurons that terminate in inner lamina II,” European Journal of Neuroscience, vol. 10, pp. 3470-3478, 1998. [35] Marie Pertin, Romain-Daniel Gosselin, and Isabelle Decosterd, “The Spared Nerve Injury Model of Neuropathic Pain,” Pain Research: Methods and Protocols, Methods in Molecular Biology, vol. 851, 2012. [36] Mette Richner, Ole J. Bjerrum, Anders Nykjaer, Christian B. Vaegter, “The Spared Nerve Injury (SNI) Model of Induced Mechanical Allodynia in Mice,” Journal of Visualized Experiments, vol. 54, e3092, DOI : 10.3791/3092, 2011. [37] Mark J. Lema, “Types of neuropathic pain,” The Neuropathy Association, 2008. [38] Maria Claudia G. Oliveira, Adriana Pelegrini-da-Silva, Claudia Herrera Tambeli, Carlos Amilcar Parada, “Peripheral mechanisms underlying the essential role of P2X3,2/3 receptors in the development of inflammatory hyperalgesia,” Pain, vol. 141, pp. 127-134, 2009. [39] Makoto Tsuda, Hidetoshi Tozaki-Saitoh and Kazuhide Inoue, “Purinergic system, microglia and neuropathic pain,” Current Opinion in Pharmacology, vol. 12, pp. 74–79, 2012. [40] Marcel Rigaud, Geza Gemes, Marie-Elizabeth Barabas, Donna I. Chernoff, Stephen E. Abram, Cheryl L. Stucky, Quinn H. Hogan, “Species and strain differences in rodent sciatic nerve anatomy: Implications for studies of neuropathic pain,” Pain, vol. 136(1-2), pp. 188-201, 2008. [41] Makoto Tsuda, Hidetoshi Tozaki-Saitoh, Kazuhide Inoue, “Pain and purinergic signaling,” Brain Research Reviews, vol. 63, pp. 222-232, 2010. [42] Ozgur Gunduz, Hakan C. Karadag, Ahmet Ulugol, “Synergistic anti-allodynic effects of nociceptin/orphanin FQ and cannabinoid systems in neuropathic mice,” Pharmacology, Biochemistry and Behavior, vol. 99, pp. 540–544, 2011. [43] Paul J. Austin, Ann Wu, Gila Moalem-Taylor, “Chronic constriction of the sciatic nerve and pain hypersensitivity testing in rats,” Journal of Visualized Experiments, vol. 61, e3393, 2012. [44] Peter J. Shortland, Beki Baytug, Agnieszka Krzyzanowska, Stephen B. McMahon, John V. Priestley, Sharon Averill, “ATF3 expression in L4 dorsal root ganglion neurons after L5 spinal nerve transection,” European Journal of Neuroscience, vol. 23, pp. 365 -373, 2006. [45] R. Alan North, “P2X3 receptors and peripheral pain mechanisms,” 252), The Journal of Physiology, vol. 554.2, pp. 301-308, 2003. [46] R. Alan North, Michael F. Jarvis, “P2X receptors as drug targets,” Molecular Pharmacology, vol. 83, pp. 759-769, 2013. [47] Rahim Mohammadi, Hadi Heydarian, Keyvan Amini, “Effect of local administration of cyclosporine A on peripheral nerve regeneration in a rat sciatic nerve transaction model,” Chinese Journal of Traumatology, vol. 17(1), pp. 12-18, 2014. [48] Ramakrishna Nirogi, Venkatesh Goura, Dhanalakshmi Shanmuganathan, Pradeep Jayarajan, Renny Abraham, “Comparison of manual and automated filaments for evaluation of neuropathic pain behavior in rats,” Journal of Pharmacological and Toxicological Methods, vol. 66, pp. 8–13, 2012. [49] Rhona Seijffers, Andrew J. Allchorne, Clifford J. Woolf, “The transcription factor ATF-3 promotes neurite outgrowth,” Molecular and Cellular Neuroscience, vol. 32, pp. 143-154, 2006. [50] Ru-Rong Ji and Gary Strichartz, “Cell Signaling and the Genesis of Neuropathic Pain,” Science’s Stke, vol. 252, re14, 2004. [51] Sanja D. Novakovic, Laura C. Kassotakis, Ian B. Oglesby, Jan A.M. Smith, Richard M. Eglen, Anthony P.D.W. Ford, John C. Hunter, “Immunocytochemical localization of P2X3 purinoceptors in sensory neurons in naive rats and following neuropathic injury,” Pain, vol. 80, pp. 273–282, 1999. [52] Sean P. Cook and Edwin W. McCleskey, “ATP, pain and a full bladder,” Nature, vol. 407, 2000. [53] Stanislava Jergova, “Neuropathic Pain Following Nerve Injury, Basic Principles of Peripheral Nerve Disorders,” InTech, ISBN: 978-953-51-0407-0, 2012. [54] Shannon D. Shields, William A. Eckert III, Allan I. Basbaum, “Spared nerve injury model of neuropathic pain in the mouse: a behavioral and anatomic analysis,” The Journal of Pain, vol. 4, pp. 465-470, 2003. [55] S. T. Eisenman, S. J. Gibbons, R. D. Singh, C. E. Bernard, J. Wu, M. G. Sarr, M. L. Kendrick, D. W. Larson, E. J. Dozois, K. R. Shen, G. Farrugia, “Distribution of TMEM100 in the mouse and human gastrointestinal tract- a noval marker of enteric nerves,” Neuroscience, vol. 240, pp. 117–128, 2013. [56] Satoshi Somekawa, Keiichi Imagawa, Hisaki Hayashi, Masahide Sakabe, Tomoko Ioka, Genki E. Sato, Ken Inada, Takaaki Iwamoto, Toshio Mori, Shiro Uemura, Osamu Nakagawa, Yoshihiko Saito, “Tmem100, an ALK1 receptor signaling-dependent gene essential for arterial endothelium differentiation and vascular morphogenesis,” Proceedings of the National Academy of Sciences, vol. 109(30), pp. 12064-9, 2012. [57] To-Jung Tseng, Chih-Cheng Chen, Yu-Lin Hsieh, Sung-Tsang Hsieh, “Effects of decompression on neuropathic pain behaviors and skin reinnervation in chronic constriction injury,” Experimental Neurology, vol. 204, pp. 574–582, 2007. [58] Tomosada Sugimoto, Gary J. Bennett, Keith C. Kajander, “Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of a chronic constriction injury, transection, and strychnine,” Pain, vol. 42, pp. 205-213, 1990. [59] Umut İrfan Üçel, Özgür Devrim Can, Ümide Demir Özkay, Yusuf Öztürk, “Antihyperalgesic and antiallodynic effects of mianserin on diabetic neuropathic pain: A study on mechanism of action,” European Journal of Pharmacology, vol. 756, pp. 92–106, 2015. [60] V. Staikopoulos, B. J. Sessle, J. B. Furness, E. A. Jennings, “Localization of P2X2 and P2X3 receptors in rat trigeminal ganglion neurons,” Neuroscience, vol. 144, pp. 208–216, 2007. [61] Xander Smit, “Struggle at the site of nerve injury- A rat sciatic nerve study on fundamental problems of peripheral nerve injury.” [62] Xin Li, Lumei Kang, Guilin Li, Huihong Zeng, Lei Zhang, Xiang Ling, Hui Dong, Shangdong Liang, Hongping Chen, “Intrathecal leptin inhibits expression of the P2X2/3 receptors and alleviates neuropathic pain induced by chronic constriction sciatic nerve injury,” Molecular Pain, vol. 9, pp. 65-73, 2013. [63] Yeon Jang, Ho-Kyung Song, Mi Young Yeom, BS, Dae Chul Jeong, “The immunomodulatory effect of pregabalin on spleen cells in neuropathic mice,” Anesthesia & Analgesia, vol. 115(4), pp. 830-6, 2012. [64] Yu-Lin Hsieh, Hao Chiang, June-Horng Lue, Sung-Tsang Hsieh, “P2X3-mediated peripheral sensitization of neuropathic pain in resiniferatoxin-induced neuropathy,” Experimental Neurology, vol. 235, pp. 316–325, 2012. [65] Yuzuru Takahashi, Yoshio Nakajima, Takashi Sakamoto, “Dermatome mapping in the rat hindlimb by electrical stimulation of the spinal nerves,” Neuroscience Letters, vol. 168, pp. 85-88, 1994. [66] Yuzuru Takahashi, Yoshio Nakajimab, “Dermatomes in the rat limbs as determined by antidromic stimulation of sensory C-fibers in spinal nerves,” Pain, vol. 67, pp. 197-202, 1996. [67] Yong Chen, Guang-Wen Li, Congying Wang, Yanping Gu, Li-Yen Mae Huang, “Mechanisms underlying enhanced P2X receptor-mediated responses in the neuropathic pain state,” Pain, vol. 119, pp. 38-48, 2005. [68] Zhenghua Xiang, Yuanchang Xiong, Ni Yan, Xiaohan Li, Yanfei Mao, Xin Ni, Cheng He, Robert H. LaMotte, Geoffrey Burnstock, Jihu Sun, “Functional up-regulation of P2X3 receptors in the chronically compressed dorsal root ganglion,” Pain, vol. 140, pp. 23-34, 2008. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/4691 | - |
dc.description.abstract | 神經痛為周邊及中樞神經系統因疾病或原發性損傷所造成,患者感受到程度不一的異常感覺,如觸摸痛、痛覺過敏、痛覺減退等。由於症狀在臨床的表現複雜且機制尚未全面了解,藥物治療效果不佳且有耐受性問題,對於疼痛機制的研究以及開發有潛力的藥物治療標的有其必要性。周邊神經損傷為造成神經痛的其中一種原因,而三磷酸腺苷 (ATP)及嘌呤受體 (Purinergic receptor)的活化則為痛覺活化的可能途徑。其中P2X3受體於先前研究發現主要表現在中小型感覺神經元,因此我們使用小鼠坐骨神經損傷(Spared nerve injury, SNI)為模型,藉此探討P2X3受體及相關分子在背跟神經節(Dorsal root ganglion, DRG)之表現。
手術後小鼠手術肢機械性刺激閾值 (mechanical threshold) 下降而敏感化 (mechanical allodynia),相對於非手術肢及手術前測試結果都有顯著差異。背跟神經節L4免疫螢光染色結果顯示,P2X3受體主要表現於中小型神經元、以及少部分大型神經元; 而手術側與對照側之P2X3受體於整個神經元族群所佔比例並無顯著差異。利用雙重染色觀察P2X3型態上的分佈,主要和表現lectin IB4的non-peptidergic受體高度重疊,並且極少與表現calcitonin gene- related peptide (CGRP)的peptidergic 受體重疊,而IB4/P2X3神經元比例在手術側較對照側為低並達到統計上差異,因此表現P2X3的神經元族群於手術側與對照側可能有型態分佈上的改變。使用網路資料庫篩選參與P2X3啟動子結合調控的可能基因,其中activating transcription factor-3 (ATF3) 之染色結果於手術側顯著上升,然而ATF3剔除小鼠接受SNI後表現之神經痛行為測試結果與wild-type組並無顯著差異,ATF3與P2X3是否具有調控的相關性仍有待探討。 在SNI小鼠模型中,假手術組於機械性刺激閾值的絕對值與差值的統計結果呈現不一致的情形,代表需要更進一步探討小鼠的痛覺行為。此外,不同行為測量儀器、神經痛模型之間的行為與分子表現差異、免疫螢光染色中大型神經元在P2X3活化所扮演之角色、SNI小鼠模型中受損與未受損神經元之分子表現、以及P2X3神經元族群分佈型態上的特性仍有許多可以探究的問題。 | zh_TW |
dc.description.abstract | Neuropathic pain refers to pains resulting from disease or damage of the peripheral or central nervous systems, and from dysfunction of the nervous system. Patients suffer from this chronic, intensively painful experience that is difficult to treat with conventional analgesic medications. Peripheral nerve injury is one of the etiologies causing neuropathic pain, and ATP seems to be strongly implicated in peripheral pain sensitization. The purinergic receptor, P2X3, a ligand-gated cation channel, is expressed in a subset of small-diameter, primary afferent neurons, and might be a potential therapeutic target to relieve pain. Previous studies showed controversial results in terms of P2X3 expression in several peripheral nerve injury models. Some claimed that a functional up-regulation of P2X3 in dorsal root ganglia, whereas some reported contradicted results. We hope to investigate the regulation of P2X3 gene expression.
Using spared nerve injury model (SNI) in mice, we found animals displayed mechanical allodynia in the spared sural territory one week after surgery and persisted at least two weeks. From the results of immunofluorescent staining to estimate the P2X3 (+) neuron ratio on lumbar (L4) dorsal root ganglia (DRG), P2X3 receptors were mainly expressed in small and medium sized neurons, while few percentages of large neurons were also discovered both in the contralateral and ipsilateral sides. The P2X3 immunoreactive neuron ratios between ipsilateral and contralateral DRG did not show significant difference, and the distribution were highly colocalized with the nonpeptidergic neurons that express IB4, but rarely co-expressed with CGRP immunoreactive neurons, which are peptidergic. The (IB4/P2X3) neuron ratios in ipsilateral DRG were statistically lower than the contralateral DRG, suggesting a morphological shift of P2X3 distribution could be happened. To screen the possible gene candidates regulating P2X3 expression on transcriptional level, we used bioimformatic web tools and further filtered by their functions. One possible molecule, activating transcription factor-3 (ATF3), was increased on the ipsilateral DRG significantly. Although the mechanical thresholds of ATF3-knockout mice after SNI were similar to those of the wild-type group, it is worth pursuing whether there exist relationship, probably with different neuropathic pain models. In our study of SNI mouse model with mechanical allodynia, inconsistency of the sham group in difference of mechanical thresholds compared to absolute values, comparison of sensory abnormalities between dynamic plantar aesthesiometer and manual von Frey filaments, pain behaviors in different neuropathic pain models and species are possible issues to be investigated. From the results of immunofluorescent staining, quantities of large sized neuron in P2X3 (+) populations, degrees and location of nerve injury, and distribution of injured and intact neurons in DRG after SNI are also required to be further clarified. | en |
dc.description.provenance | Made available in DSpace on 2021-05-14T17:45:21Z (GMT). No. of bitstreams: 1 ntu-104-R02454016-1.pdf: 1648448 bytes, checksum: 8988a259936ca811fe421a2f27a75d05 (MD5) Previous issue date: 2015 | en |
dc.description.tableofcontents | 口試委員會審定書 #
致謝 i 中文摘要 ii ABSTRACT iii CONTENTS v LIST OF FIGURES & TABLES vii Chapter 1 Introduction 1 1.1 Neuropathic pain and peripheral nerve injury 1 1.2 Purinergic receptors and pain 3 1.3 Controversial Results of P2X3 Expression in Peripheral Nerve Injury Models 4 Chapter 2 Materials & Methods 7 2.1 Animals 7 2.2 Spared nerve injury model 7 2.3 Animal behavior evaluation 8 2.4 Immunofluorescent staining of DRG 8 2.5 Genotyping of the mice 9 2.6 Bioinformatic web tools 10 2.7 Data analysis 10 Chapter 3 Results 12 3.1 Neuropathic pain behavior- mechanical allodynia induced by SNI 12 3.2 P2X3 expression in the lumbar DRGs after SNI 13 3.3 Increased expression of ATF3 in the ipsilateral DRGs and the assessment of neuropathic pain behavior of ATF3-knockout mice receiving SNI 15 Chapter 4 Discussion 17 4.1 Mechanical allodynia of SNI mouse model using dynamic plantar aesthesiometer 18 4.2 P2X3 immunoreactive neuron ratio in the ipsilateral lumbar DRG of SNI mice 21 4.3 Neuropathic pain behaviors in the ATF3-knockout mice 24 FIGURES & TABLES 25 REFERENCE 53 | |
dc.language.iso | en | |
dc.title | 小鼠背根神經節於神經痛之分子表現:以坐骨神經損傷為模式 | zh_TW |
dc.title | Molecular Expression in Dorsal Root Ganglia of Neuropathic Pain Mice Induced by Spared Nerve Injury | en |
dc.type | Thesis | |
dc.date.schoolyear | 103-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 陳志成(Chih-Cheng Chen),曾明宗(Ming-Tsung Tseng) | |
dc.subject.keyword | 坐骨神經損傷模型(SNI),神經痛,P2X3受體,激活轉錄因子-3(ATF3),背跟神經節(DRG),痛覺受體, | zh_TW |
dc.subject.keyword | Spared nerve injury(SNI),Neuropathic pain,P2X3,Activating transcription factor-3(ATF3),Dorsal root ganglion(DRG),Nociceptor, | en |
dc.relation.page | 59 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2015-07-15 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 腦與心智科學研究所 | zh_TW |
顯示於系所單位: | 腦與心智科學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-104-1.pdf | 1.61 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。